ImageneBio (IMA) Accumulated Expenses (2020 - 2025)

ImageneBio has disclosed Accumulated Expenses across 6 years of filings, most recently posting $2.9 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $2.9 million, down 16.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (down 16.53% YoY), and the FY2025 annual result was $2.9 million, down 16.53% from the prior year.
• Accumulated Expenses came in at $2.9 million for Q4 2025 at ImageneBio, down from $6.9 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.2 million in Q3 2023 to a low of $483000.0 in Q2 2025.
• The 5-year median for Accumulated Expenses is $3.9 million (2024), against an average of $4.4 million.
• Across the five-year window, Accumulated Expenses surged 432.72% in 2022 and tumbled 78.34% in 2024, its largest moves.
• ImageneBio's Accumulated Expenses stood at $2.8 million in 2021, then jumped by 197.01% to $8.3 million in 2022, then plunged by 60.31% to $3.3 million in 2023, then rose by 4.5% to $3.5 million in 2024, then dropped by 16.53% to $2.9 million in 2025.
• The last three Accumulated Expenses figures came in at $2.9 million (Q4 2025), $6.9 million (Q3 2025), and $483000.0 (Q2 2025), per Business Quant data.